Summit Global Investments’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-34,325
| Closed | -$907K | – | 501 |
|
|
2022
Q3 | $907K | Buy |
34,325
+587
| +2% | +$15.5K | 0.08% | 206 |
|
|
2022
Q2 | $1.5M | Buy |
33,738
+1,555
| +5% | +$69.1K | 0.13% | 163 |
|
|
2022
Q1 | $1.59M | Sell |
32,183
-3,536
| -10% | -$175K | 0.12% | 175 |
|
|
2021
Q4 | $1.82M | Sell |
35,719
-1,500
| -4% | -$76.4K | 0.12% | 155 |
|
|
2021
Q3 | $2.08M | Sell |
37,219
-1,100
| -3% | -$61.4K | 0.16% | 123 |
|
|
2021
Q2 | $1.64M | Sell |
38,319
-146
| -0.4% | -$6.25K | 0.1% | 159 |
|
|
2021
Q1 | $1.61M | Buy |
38,465
+7,021
| +22% | +$293K | 0.1% | 150 |
|
|
2020
Q4 | $1.46M | Buy |
31,444
+1,255
| +4% | +$58.4K | 0.15% | 125 |
|
|
2020
Q3 | $1.28M | Buy |
30,189
+2,189
| +8% | +$93K | 0.13% | 110 |
|
|
2020
Q2 | $1.34M | Buy |
28,000
+13,800
| +97% | +$662K | 0.15% | 97 |
|
|
2020
Q1 | $653K | Buy |
+14,200
| New | +$653K | 0.1% | 137 |
|